切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (05) : 305 -309. doi: 10.3877/cma.j.issn.1674-0807.2016.05.011

综述

隐匿性乳腺癌诊治的争议和展望
郭美琴1,(), 宋伟1   
  1. 1.030001 太原,山西医科大学第二医院乳腺外科
  • 收稿日期:2016-01-22 出版日期:2016-10-01
  • 通信作者: 郭美琴

Controversy and prospect in diagnosis and treatment of occult breast cancer

Meiqin Guo(), Wei Song   

  • Received:2016-01-22 Published:2016-10-01
  • Corresponding author: Meiqin Guo
引用本文:

郭美琴, 宋伟. 隐匿性乳腺癌诊治的争议和展望[J/OL]. 中华乳腺病杂志(电子版), 2016, 10(05): 305-309.

Meiqin Guo, Wei Song. Controversy and prospect in diagnosis and treatment of occult breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2016, 10(05): 305-309.

隐匿性乳腺癌是一种少见的特殊类型乳腺癌,其准确的定义、诊断与治疗目前均存在争议。 笔者对相关文献进行综述,探寻其诊断随着医学科技进步所发生的变化,提出思考和展望,希望成立一个国际隐匿性乳腺癌患者登记网,以便于纵向研究和制定全球治疗标准。

[1]
Lloyd MS, Nash AG. ‘Occult' breast cancer[J]. Ann R Coll Surg Engl,2001,83(6):420-424.
[2]
Halsted WS.The results of radical operations for the cure of carcinoma of the breast[J]. Ann Surg,1907,46(1):1-19.
[3]
Fitts WT Jr, Horn RC Jr.Occult carcinoma of the breast[J].J Am Med Assoc,1951,147(15):1429-1433.
[4]
Dalsace J. Radiography of the breast;a new technic:logetron printing[J].C R Soc Fr Gyncol,1957,27(8):360-362.
[5]
Egan RL.Experience mammography in a tumor institution.Evaluation of 1,000 studies[J]. Radiology,1960,75:894-900.
[6]
Malone LJ, Frankl G, Dorazio RA, et al. Occult breast carcinomas detected by xeroradiography: clinical considerations[J]. Ann Surg,1975,181(2):133-136.
[7]
Lieberman S, Sella T, Maly B, et al. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma[J].Isr Med Assoc J,2008,10(6):448-452.
[8]
Zuhair AR, Maron AR. Occult bilateral invasive lobular carcinoma of the breast presenting as gastroduodenal metastases: a case report[J].Breast Dis,2015,35(1):63-65.
[9]
Wagner J, Nerlich A, Schepp W. Diffuse mucosal gastric and coecal metastasis from occult breast cancer[J]. Dtsch Med Wochenschr,2009,134(17):879-882.
[10]
Razzetta F, Tassara E, Saro F, et al. Rare abdominal metastases from occult lobular breast cancer: report of two cases[J]. Updates Surg,2011,63(2):129-133.
[11]
Kinoshita S, Hirano A, Kobayashi S, et al. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes:report of a case[J]. Breast Cancer,2010,17(1):71-74.
[12]
Hanaoka T, Fujimori, Shingu K, et al. A case of occult breast cancer with paraneoplastic polyneuropathy[J]. Breast Cancer,1997,4(3):187-191.
[13]
Wu CY, Gao HW, Huang WH, et al. Infection-like acral cutaneous metastasis as the presenting sign of an occnlt breast cancer[J]. Clin Exp Dermatol,2009,34(7):e409-410.
[14]
Caroli E, Salvati M, Giangaspero F, et al. Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma[J].Neurosurg Rev,2006,29(1):49-54.
[15]
Odzak A, Geliberti F, Farace G,et al. Pancreatic tumor: an unusual presentation of an occult breast carcinoma[J]. Acta Gastroenterol Latinoam,2001,31(5):395-398.
[16]
郑新宇,马帅.隐匿性乳腺癌诊断与治疗[J].中国实用外科杂志,2013,33(3):181-184.
[17]
郝春芳,王淑玲,佟仲生. 1 例转移性隐匿性乳腺癌的临床诊治[J].中国肿瘤临床,2013,40(1):55-59.
[18]
Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendation from the society of breast imaging and ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer[J]. J Am Coll Radiol,2010,7(1):18-27.
[19]
Ahmed I, Dharmarajan K, Tiersten A, et al. A unique presentation of occult primary breast cancer with a review of the literature[J]. Case Rep Oncol Med,2015,2015:102 963.
[20]
Pentheroudakis G,Lazaridis G,Pavlidis N. Axillary nodal metastases from carcinoma of unknown primary(CUPAx):a systematic review of published evidence[J].Breast Cancer Res Treat,2010,119(1):1-11.
[21]
Fayanju OM, Jeffe DB, Margenthalar JA. Occult primary breast cancer at comprehensive cancer center[J]. J Surg Res,2013,158 (2):684-689.
[22]
Walker GV, Smith GL, Perkins GH, et al. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis[J].Cancer,2010,116(17):4000-4006.
[23]
郝晓甍,张晟,刘晶晶,等.隐性乳腺癌的预后相关性分析[J]. 中华医学杂志,2014,96 (36):2808-2811.
[24]
Walter B. Not every form of breast cancer can be demarcated with MRI[J]. Radiologe,2010,50(10):843-844.
[25]
Fayanju OM, Stoll CR, Fowler S,et al. Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis [J]. Ann Surg Oncol, 2013,20 (10):3308-3316.
[26]
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2013 版)[J].中国癌症杂志,2013,23(8):637-684.
[27]
Candelaria R, Fornage BD. Second-look US examination of MRdetected breast[J]. J Clin Ultrasound,2011,39(3):115-121.
[28]
Aracava MM, Chojniak R, Souza JA, et al. Identification of occult breast lesions detected by magnetic resonance imaging with targeted ultrasound: a prospective study[J]. Eur J Radiol,2014, 83(3):516-519.
[29]
赵玉年,唐金海,沈文荣,等.MRI 引导定位活检对隐匿性乳腺癌的诊治价值[J].影像诊断与介入放射学,2015,24(4):317-321
[30]
de Bresser J, de Vos B, van der Ent F, et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review[J]. Eur J Surg Oncol,2010,36(2):114-119.
[31]
Olson JA Jr, Morris EA, Van Zee KJ,et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer[J]. Ann Surg Oncol,2000,7(6):411-415.
[32]
Zebic-Sinkovec M, Kadivec M, Podobnik G, et al. Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI:a case report[J]. Radiol Oncol,2010,44(4):228-231.
[33]
Sanguinetti A, Polistena A, D'Ermo G, et al. Axillary metastases from occult breast cancer. Our experience [J]. Ann Ital Chir, 2014,85(ePub).pii: S2239253X14022129.
[34]
Wang X, Zhao Y, Cao X. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases[J]. Breast J,2010,16(1):32-37.
[35]
Wang J,Talmon G,Hankins JH,et al. Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis[J]. Case Rep Oncol,2012,5(1):9-16.
[36]
牛昀,范宇,傅西林.隐性乳腺癌的全乳腺次连续大切片检查[J].中华肿瘤杂志,1995,17(4):298-300.
[37]
Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual[J]. CA Cancer J Clin,2006,56(1):37-47; quiz 50-51.
[38]
佟易凡,张瑾,刘红,等.隐匿性乳腺癌与非隐匿性乳腺癌临床特征比较[J/CD].中华乳腺病杂志:电子版,2008,2(6):653-660.
[39]
Cameron HC. An address entitled some clinical facts regarding mammary cancer[J].Br Med J,1909,1(2514):577-582.
[40]
Ellerbroek N,Holmes F,Singletary E,et al. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin[J]. Cancer,1990,66(7):1461-1467.
[41]
Barton SR, Smith IE, Kirby AM, et al. The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy [J]. Eur J Cancer, 2011,47 (14):2099-2106.
[42]
Rueth NM, Black DM, Limmer AR, et al. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer[J]. Ann Surg Oncol,2015,22(1):90-95.
[43]
Foroudi F,Tiver KW. Occult breast carcinoma presenting as axillary metastases[J].Int J Radiat Oncol Biol Phys,2000,47(1):143-147.
[44]
He M, Tang LC, Yu KD, et al. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer[J]. Eur J Surg Oncol,2012,38(11):1022-1028.
[45]
Sohn G,Son BH,Lee SJ,et al. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study[J]. J Surg Oncol,2014,110(3):270-274.
[46]
Wang J, Zhang YF, Wang X,et al. Treatment outcomes of occult breast carcinoma and prognostic analyses[J]. Chin Med J (Engl),2013,126(16):3026-3029.
[47]
杨雪,王靖,张业繁,等.隐匿性乳腺癌的治疗选择及预后因素分析[J].中国肿瘤临床,2015,42(10):509-512.
[48]
胡薇, 施俊义, 盛湲,等. 特殊类型隐匿性乳腺癌保乳治疗效果观察[J].第二军医大学学报,2010,31(2):224-225.
[49]
邵志敏. 乳腺癌外科治疗发展趋势[J]. 外科基础与临床,2006,11(2):89-91.
[50]
Merson M,Andreola S,Galimberti V,et al.Breast carcinoma presenting as axillary metastases without evidence of a primary tumor[J].Cancer,1992,70(2):504-508.
[51]
马宏民,胡玲玉,王树森.隐匿性乳腺癌的诊断与治疗[J].中国普外基础与临床杂志,2014,21(5):544-548.
[52]
Vlastos G,Jean ME,Mirza AN,et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases[J]. Ann Surg Oncol,2001,8(5):425-431.
[53]
Altan E,Altundag K. Clinical and pathological characteristics of occult breast cancer and review of the literature[J]. J BUON,2011,16(3):434-436.
[54]
Montagna E, Bagnardi V, Rotmensz N, et al. Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation[J]. Breast Cancer Res Treat,2011,129(3):867-875.
[55]
Ping S, Ming WH, Bin SH, et al. Comparison of clinical characteristics between occult and non-occult breast cancer[J]. J BUON,2014,19(3):662-666.
[56]
He M, Liu H, Jiang Y. A case report of male occult breast cancer first manifesting as axillary lymph node metastasis with part of metastatic mucinous carcinoma [J]. Medicine (Baltimore),2015,94 (25):e1038.
[57]
陈朗,王文武,欧阳学农.隐匿性男性乳腺癌1 例[J].肿瘤学杂志,2014,20(11):965-966.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要